Pronova BioPharma's Sandefjord plant
The production facilities in Norway are located in Sandefjord, south of Oslo. The plant plays a key role in Pronova BioPharma’s
efforts to meet the growing demand for Omacor/Lovaza. The plant utilizes a unique and complex manufacturing process, which
results in the highly purified, omega-3 derived, pharmaceutical product Omacor/Lovaza
The staff of around 128 employees is highly skilled, with specialised employees, engineers, laboratory technicians and process
operators. Since 2004, investments of around NOK 650 million have been made in the plant, increasing production capacity by
300 per cent in this period.
Investments have also been made in a new and improved purification system, which will be implemented during 2008. Current
annual production capacity is 1 200 metric tons. In order to meet the growing demand, Pronova BioPharma is building a second
plant in Kalundborg, Denmark, which will double the total capacity .
Read more…
Click here for map
